HALEON GROUP OF CO.
Company Snapshot
Founded: 2022
Entity Type: Public
Employees: 24,561
Region: North America
Revenue: $14,354.9 Millions
Revenue Year: 2024
Headquarter: Weybridge, U.K.
Key Geographics: North America, EMEA & LatAm, APAC
Corporate Address: The Heights Building 5, First Floor The Heights Weybridge Surrey KT13 0NY U.K. Tel. +44-1932-95-9500 www.haleon.com
Company Overview
In 2022, GSK separated its Consumer Healthcare business, establishing Haleon plc as an independent consumer health company. Haleon Group of Companies holds leading positions in five global market categories: Oral Health, Vitamins, Minerals, and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Others. The company offers OTC drugs, vitamins, and supplements in all categories. Haleon’s nine large-scale multinational brands, which the company defines as Power Brands, include Advil, Centrum, Otrivin, Panadol, periodontal, Polident, Sensodyne, Theraflu, and Voltaren.
The company has a broad market reach, with a presence in over 100 countries.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
HALEON GROUP OF CO. In News
Company's Business Segments
- Oral Health : This segment includes Sensodyne, Polident, Parodontax, Others.
- Vitamins, Minerals and Supplements : This segment includes Centrum, Caltrate, Emergen-C, Others.
- Pain Relief : This segment includes Voltaren, Panadol, Advil, Others.
- Respiratory Health : This segment includes Otrivin, Theraflu, Flonase, Others.
- Digestive Health and Other : This segment includes Tums, Eno, Nexium, others.
Applications/End User Industries
- Pharmaceutical
- Healthcare
- Biotechnology
- Vitamins
- Clinics
BCC Research Beacon 